Abstract:Transforming Growth Factor-Beta-Activated Kinase 1 (TAK1/MAP3K7), along with its upstream regulators TAK1-Binding Protein 2 (TAB2) and the catalytic alpha-subunit of Protein Kinase A (PKA-Cα/PRKACA), has been identified as a pivotal player in regulation of developmental processes. Haploinsufficiency of TAB2 causes Congenital Heart Disease (CHD) and rare variants in PKA-Cα and TAK1 cause cardioacrofacial dysplasia (CAFD), and Frontometaphyseal Dysplasia (FMD) and cardiospondylocarpofacial syndrome (CSCFS), respectively, rare multisystem syndromes, where CHD may appear in the clinical spectrum. We hypothesized that TAK1 plays a significant role in heart development and CHD and addressed this by genetic analysis in CHD patient cohorts and experiments in cell and animal models. Exome sequencing data from 1,471 CHD patients with extracardiac anomalies (syndromic CHD, sCHD), 2,405 patients with nonsyndromic CHD (nsCHD) and 45,082 controls showed increased burden of rare and variants in sCHD, but not in nsCHD. Detailed characterization of and zebrafish mutants revealed cardiac defects (dilated atrium, trabeculation defects, tachycardia and reduced contractility) as well as extracardiac developmental anomalies. RNA sequencing of mutant hearts showed downregulation of genes encoding core cardiac transcription factors, sarcomeric proteins and extracellular matrix proteins. Experiments with cell cultures and analysis of zebrafish larvae and gastruloids indicated that TAK1 via TAB2 and PKA-Cα is activated at the primary cilium during cardiomyogenesis and that TAK1 activation at this site is enhanced by cardiomyogenic signaling molecules, including ligands of the TGFB/BMP superfamily. Consistent with these findings, CRISPR/Cas9-mediated editing of TAK1 or administration of small molecule inhibitors targeting TAK1 inhibited ciliary signaling and cardiomyocyte differentiation , while FMD-causing mutations in TAK1 reduced its ciliary localization. In conclusion, our data establishes a central role for TAK1 and its upstream regulators in cardiac development and syndromic CHD, coordinated via the primary cilium.

TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages

TAK1 is an Essential Regulator of BMP Signalling in Cartilage.

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Ablation of Tak1 in Osteoclast Progenitor Leads to Defects in Skeletal Growth and Bone Remodeling in Mice

Expression Profiling and Functional Analysis of Candidate Col10a1 Regulators Identified by the TRAP Program

SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation

TGF-beta/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage.

Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development

Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways

Signaling Cascades Governing Cdc42-Mediated Chondrogenic Differentiation and Mensenchymal Condensation

gp130/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes

Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.

Receptor‐regulated and Inhibitory Smads Are Critical in Regulating Transforming Growth Factorβ–mediated Meckel's Cartilage Development

TAK1 operates at the primary cilium in non-canonical TGFB/BMP signaling to control heart development

Inhibition of transforming growth factor β-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis

Zbtb20 Regulates the Terminal Differentiation of Hypertrophic Chondrocytes Via Repression of Sox9

Foxc1 and Foxc2 regulate growth plate chondrocyte maturation towards hypertrophy in the embryonic mouse limb skeleton

Skeletal cell YAP and TAZ combinatorially promote bone development

SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity

NFATc1 marks articular cartilage progenitors and negatively determines articular chondrocyte differentiation